 LAWRENCEVILLE, N.J., Sept. 12, 2022 GLOBE NEWSWIRE -- Celsion Corporation NASDAQ: CLSN, a clinical-stage drug development company, announces that Dr. Corinne Le Goff, President and Chief Executive Officer, will present a company overview at the H.C. Wainwright 24th Annual Global Investment Conference on September 13th at 4:30 p.m. Eastern time. The presentation will available live and on-demand here. 